In Brief Oxford team receives $800K from CRUK to create vaccine for ovarian cancer October 04, 2024Vol.50 No.37
Clinical Roundup Carvykti extended OS in r/r MM vs standard therapies in phase III trial October 04, 2024Vol.50 No.37
Clinical Roundup Circadian disruption, gut microbiome changes linked to CRC progression in mice October 04, 2024Vol.50 No.37
Clinical Roundup Data validates multimodal AI biomarker’s ability to help inform treatment decisions omCSPC October 04, 2024Vol.50 No.37
Clinical Roundup PATH tool and study reveal cancer cells “shape-shift” to evade treatment October 04, 2024Vol.50 No.37
Clinical Roundup Crofelemer relieves diarrhea in breast cancer subgroup in phase III trial October 04, 2024Vol.50 No.37
Clinical Roundup UT Health San Antonio creates pancreatic cancer organoid October 04, 2024Vol.50 No.37
Clinical Roundup Barcode technology could help diagnose cancer more precisely October 04, 2024Vol.50 No.37
Clinical Roundup Xcell Biosciences, AmplifyBio expand collaboration with cell and gene therapy manufacturing capabilities October 04, 2024Vol.50 No.37
Clinical Roundup First-in-human study of novel inhibitor shows promise in MTAP-deleted solid tumors October 04, 2024Vol.50 No.37
